Acne 

Actinic Keratosis 

Aesthetics

Alopecia

Biologic Treatments for Moderate to Severe Atopic Dermatitis 

Atopic Dermatitis 

COVID-19

Chronic Hand Eczema

Drug Watch

Eczema

General Dermatology 

Hidradenitis Suppurativa

Melasma

NP and PA

Pediatric Dermatology

Pigmentary Disorders 

Practice Management 

Precision Medicine and Biologics

Prurigo Nodularis

Emerging Therapies Plaque Psoriasis

Treatments for Plaque Psoriasis 

Psoriasis 

Psoriatic Arthritis 

Rare Disease

Rosacea 

Skin Cancer (Nonmelanoma)

Skin Cancer

Vitiligo

Wound Care

News

Media

Around the Practice

Between The Lines

Case-Based Peer Perspective

Clinical Case Collective

DermView

Expert Perspectives

Fellows Face Off

Frontline Forum

Medical World News

Patient Perspectives

Podcasts

Readout360

Recognize and Refer

Conferences

Conference Coverage

Conference Listing

Events

Case-Based Roundtable

Publication

Dermatology Times

CME/CE

Resources

DermIQ

Interactive Tools

Job Board

Partner Perspectives

Polls

Editorial Advisory Board

Partners

Subscribe

Kaitlyn Bader is the assistant managing editor of 

 and joined the MJH Life Sciences team in June 2022. She attended Otterbein University in Westerville, Ohio, and earned a Bachelor of Arts degree in literary studies with minors in creative writing and film studies. Prior to health care news, Kaitlyn worked in industrial marketing. She enjoys cooking, reading, and tending to her house plants.

Articles

At the 2024 SDPA Fall Conference, Hilary Baldwin, MD, highlighted innovative strategies for managing complex rosacea cases, the importance of combination approaches, and a slowing treatment pipeline.


Advances and Challenges in Rosacea Treatment: Insights From Hilary Baldwin, MD 

 At the 2024 SDPA Fall Conference, Hilary Baldwin, MD, highlighted the superiority of branded acne therapies, the necessity of tailored regimens, and the value of structured PA education.

Advocating for Innovation and Education in Acne Care

Take this quiz to see if you are leveraging the latest research in acne treatment.

Test Your Knowledge: Acne Pearls From SDPA

At the SDPA Fall Conference, Miranti emphasized the importance of targeted, comprehensive acne therapies and inspired attendees to embrace pediatric dermatology as a rewarding subspecialty.

Shanna Miranti, MPAS, PA-C, Shares Expert Acne and Pediatric Dermatology Insights 

About

Advertise

Contact Us

Do Not Sell My Information

Terms and Conditions

Privacy Policy

Dermatology Times and Multimedia Medical, LLC

Facebook

Linkedin

Topics

Acne

Pigmentary Disorders

Practice Management

Psoriasis

Psoriatic Arthritis

Rosacea

1rem

Authors

Acne scars are potentially socially debilitating lifelong reminders of the condition. Fortunately, modern laser therapy allows dermatologists to offer their patients hope for improvement. Prior to initiating laser therapy for acne scars it is important to consider the types of scars encountered.

Combining correct laser device with type of acne scar boosts clearance

Revolutionized by the advent of fractional laser technology, laser surgery for scars continues to evolve. However, clinicians continue to be confronted with a wide variety of scar types without a well-established treatment algorithm.

Laser options grow for hypertrophic, keloid scarring

Final Thoughts: The Importance of Comparative Studies in AD

Panelists offer concluding insights and emphasize the critical role of comparative studies in advancing atopic dermatitis treatment strategies.

clinical

Video Series

Hyperhidrosis is not rare. According to the 

, approximately 385 million people worldwide live with hyperhidrosis.

In fact, they note that the amount of people living with chronic, excessive sweating is even higher than the amount of people living with other dermatologic conditions like psoriasis.

Just how common is hyperhidrosis in real-world comparisons?

The prevalence of hyperhidrosis is much higher in younger populations than in the general population, with 8.8% of individuals between the ages of 18 to 39 years old living with the condition. 

When comparing these statistics to everyday, common occurrences like hair color, the number of people with hyperhidrosis is greater than the 1% of individuals with natural red hair and 2% of individuals with natural blond hair. 

Despite how common hyperhidrosis is, it is estimated that 27% of those with the condition never receive a diagnosis.

 wants to hear from you. What percentage of the global population is estimated to have hyperhidrosis?

 to share your hyperhidrosis insights or research.

Albert. Fact check: Hyperhidrosis - International Hyperhidrosis Society: Official site. Home - International Hyperhidrosis Society. October 24, 1970. Accessed November 16, 2023. 

https://www.sweathelp.org/home/news-blog/542-fact-check-hyperhidrosis.html

Hyperhidrosis affects approximately 385 million people globally, surpassing the prevalence of other dermatologic conditions like psoriasis. It is notably more common in younger populations, with 8.8% of individuals aged 18 to 39 experiencing the condition. Comparatively, hyperhidrosis is more prevalent than natural red or blond hair, which affects 1% and 2% of the population, respectively. Despite its prevalence, 27% of those with hyperhidrosis remain undiagnosed. The article encourages engagement during Hyperhidrosis Awareness Month to share insights and research on the condition.

Click here to answer this week's poll for Hyperhidrosis Awareness Month.

Polls 

POLL: What Percent of the Global Population is Estimated to Have Hyperhidrosis?

, symptoms of psoriasis often start between the ages of 15 and 25.

 However, symptoms of psoriasis can start at any age and stage of life.

The majority of patients with psoriasis will experience their first flare when they are between the ages of 15 and 35. Despite this, nearly 1 in 3 patients are under the age of 20 at the disease's first onset.

"While it can begin at any age, psoriasis has 2 peaks of onset, the first at age 20 to 30 years and the second at age 50 to 60 years," according to April Armstrong, MD, MPH.

 "It affects men and women equally but is more common in non-Hispanic whites. Some patients are more prone to developing psoriasis, especially if there is a family member with psoriasis."

Psoriasis: Causes, triggers and treatments. The National Psoriasis Foundation: National Psoriasis Foundation. Accessed August 4, 2023. 

https://www.psoriasis.org/about-psoriasis/

Psoriasis typically manifests between ages 15 and 35, with two onset peaks at 20-30 and 50-60 years. It affects men and women equally, predominantly in non-Hispanic whites. Approximately one-third of patients experience their first symptoms before age 20. Genetic predisposition plays a significant role, especially if a family member has psoriasis. The condition can begin at any age, highlighting the importance of awareness across all demographics. Understanding these patterns aids in early diagnosis and management, improving patient outcomes.

This Psoriasis Awareness Month, test your knowledge of the condition. Click here to answer this week's poll.

POLL: At What Age Do Symptoms of Psoriasis Often Start?

Dermatology physician associates took a break from learning and networking to give back to the community during the Society of Dermatology Physician Associates (SDPA) 2024 Fall Dermatology Conference in Las Vegas, Nevada, by volunteering with the Sun Bus.

PA clinician-volunteers at the Sun Bus, which was parked outside of the conference hotel, screening individuals for skin cancer and sun damage as well as educating interested individuals about sun dangers and sun protection in conjunction with the Sun Bus. The event was organized by the philanthropic arm of the SDPA, 

. DPAF hosted a similar sun cancer screening with the Sun Bus during the 2024 Society of Dermatology Physician Associates Summer Conference in San Diego, California, in June.

DPAF Sun Bus 

Established in 2015 to help dermatology PAs expand their leadership and contributions to the field of dermatology, the mission of the Dermatology PA Foundation (DPAF) is to “inspire and invest in Derm PAs to succeed in professional development and philanthropic service to impact communities and provide inclusion for all.” Faseeha Raza, MMS, PA-C, the current chair of the organization, is proud of its commitment to give back to the community and has encouraged the sense of volunteerism.

The Sun Bus, which was acquired in May 2019, comes courtesy of the Colorado Melanoma Foundation. Its goal is to deliver free skin checks and promote sun safety and skin cancer awareness.

about her role with DPAF. “My No. 1 goal would be to cause brand awareness, and letting people know why DPAF exists,” she told 

in an exclusive interview. “So my goal would be to promote our programming, such as Medical Mission Academy, talks in a box, professional development, and research. And knowing all these, I'm very confident a lot of PAs would be interested in becoming part of it and volunteer for it.”

Are you attending the 2024 SDPA Fall Conference? Share your impressions and highlights with your colleagues. Email DTEditor@mmhgroup.com

Dermatology physician associates participated in community service during the SDPA 2024 Fall Dermatology Conference by volunteering with the Sun Bus to provide skin cancer screenings and sun safety education. This initiative, organized by the Dermatology PA Foundation (DPAF), reflects its mission to enhance professional development and community impact. The Sun Bus, acquired from the Colorado Melanoma Foundation, aims to increase skin cancer awareness. Faseeha Raza, chair of DPAF, emphasizes promoting the foundation's programs to encourage more PAs to engage in volunteerism and professional growth.

Dermatology physician associates via DPAF conduct skin checks at the Sun Bus during the Fall Conference. 

Derm PAs Look to Give Back: Volunteering at the Sun Bus

I'm sorry, but it seems there is no content provided for me to summarize and extract key takeaways from. Could you please provide the text of the article

Test your knowledge on the foundation leading to the development of biologics to treat atopic dermatitis.

QUIZ: What Are the Major Cytokines Driving Atopic Dermatitis?

November is Hyperhidrosis Awareness Month. Get comprehensive diagnosis, treatment, and coverage/reimbursement information through the International Hyperhidrosis Society at 

1. Walling HW. Primary hyperhidrosis increases the risk of cutaneous infection: a case-control study of 387 patients. 

2009 Aug;61(2):242-6. doi:10.1016/j.jaad.2009.02.038. Epub 2009 Apr 23. PMID: 19395123.

2. Bahar R, Zhou P, Liu Y, et al.The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH). 

 2016 Dec;75(6):1126-1133. doi:10.1016/j.jaad.2016.07.001. Epub2016 Aug 25. PMID: 27567033.

3. Baker LB. Physiology of sweat gland function: The roles of sweating and sweat composition in human health. 

. 2019;6(3):211-259. Published 2019 Jul 17.doi:10.1080/23328940.2019.1632145

4. Doolittle J, Walker P, Mills T, et al. Hyperhidrosis: an update on prevalence and severity in the United States. 

2016;308(10):743-749. doi:10.1007/s00403-016-1697-9

5. American Academy of Dermatology, 2019 Annual Meeting, Prevalence of Anxiety, Depression and Attention Deficit Disorder (ADD) in Patients with Primary Hyperhidrosis, https://server.aad.org/eposters/view/Abstract.aspx?id=8424

6. Hund M, Kinkelin I, Naumann M, et al. Definition of axillary hyperhidrosis by gravimetric assessment. 

2002 Apr;138(4):539-41. doi: 10.1001/archderm.138.4.539. PMID:11939828.

7. Autism Spectrum Disorder (ASD) Data & Statistics. Centers for Disease Control and Prevention website. https/www.cdc.gov/ncbddd/autism/data.html. Feb. 12, 2018. Accessed Oct. 22, 2020.

8. Key statistics for melanoma skin cancer. American Cancer Society website. https://www.cancer.org/cancer/melanoma-skin-cancer/about/key-statistics.html. Jan 8, 2020. Accessed Oct. 22, 2020.

9. Food allergy facts and statistics. Food Allergy Research & Education website. https://www.foodallergy.org/resources/facts-and-statistics. Accessed Oct. 22, 2020.

10. Psoriasis Statistics. National Psoriasis Foundation website. https://www.psoriasis.org/psoriasis-statistics/. Oct. 8, 2020. Accessed Oct. 22, 2020.

Hyperhidrosis Awareness Month in November emphasizes the importance of understanding and managing hyperhidrosis, a condition that can lead to increased risk of cutaneous infections and is associated with anxiety and depression. Resources for diagnosis, treatment, and reimbursement are available through the International Hyperhidrosis Society. Studies highlight the prevalence and severity of hyperhidrosis, as well as its psychological impact. The condition is defined by gravimetric assessment, and its management is crucial for improving patient quality of life. Awareness efforts aim to enhance knowledge and support for affected individuals.

November is Hyperhidrosis Awareness Month - test your knowledge on the subject.

Jeremy Green, M.D.

Articles

Latest Updated Articles